REGENXBIO (RGNX) News Today $8.68 -0.38 (-4.19%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$8.85 +0.17 (+1.95%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RGNX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period REGENXBIO Announces Publication of Preclinical Results Demonstrating ...July 11 at 9:10 PM | morningstar.comMREGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular DystrophyJuly 10 at 12:04 PM | prnewswire.comRGNX | REGENXBIO Inc. Annual Income Statement - MarketWatchJuly 6, 2025 | marketwatch.comJanney Montgomery Scott LLC Makes New Investment in REGENXBIO Inc. (NASDAQ:RGNX)July 4, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsJune 30, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 283,399 Shares of REGENXBIO Inc. (NASDAQ:RGNX)June 16, 2025 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Stock Price Up 6.1% - What's Next?June 11, 2025 | marketbeat.comA Glimpse Into The Expert Outlook On Regenxbio Through 8 AnalystsJune 9, 2025 | benzinga.comREGENXBIO's (RGNX) Buy Rating Reaffirmed at Chardan CapitalJune 9, 2025 | marketbeat.comRegenxbio's RGX-121 Could Become The New Standard Of Care In Hunter SyndromeJune 6, 2025 | seekingalpha.comREGENXBIO updates Phase 1/2 data for Duchenne candidateJune 5, 2025 | msn.comEarly Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, LongerJune 5, 2025 | benzinga.comREGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202June 5, 2025 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 5, 2025 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Shares Up 13.5% - Still a Buy?June 3, 2025 | marketbeat.comShort Interest in REGENXBIO Inc. (NASDAQ:RGNX) Expands By 21.9%June 3, 2025 | marketbeat.comBank of America Corp DE Reduces Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)June 3, 2025 | marketbeat.comREGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202June 2, 2025 | prnewswire.comTwo Sigma Advisers LP Acquires 112,000 Shares of REGENXBIO Inc. (NASDAQ:RGNX)June 1, 2025 | marketbeat.comTwo Sigma Investments LP Acquires 263,495 Shares of REGENXBIO Inc. (NASDAQ:RGNX)June 1, 2025 | marketbeat.comFY2026 EPS Estimates for REGENXBIO Increased by AnalystMay 31, 2025 | marketbeat.comMillennium Management LLC Buys 1,061,187 Shares of REGENXBIO Inc. (NASDAQ:RGNX)May 26, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires 75,652 Shares of REGENXBIO Inc. (NASDAQ:RGNX)May 25, 2025 | marketbeat.comQ2 Earnings Forecast for REGENXBIO Issued By Leerink PartnrsMay 24, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Purchased by Jane Street Group LLCMay 23, 2025 | marketbeat.comRegenxbio at RBC Conference: Strategic Moves and Clinical ProgressMay 22, 2025 | investing.comREGENXBIO FY2025 EPS Forecast Reduced by Chardan CapitalMay 21, 2025 | marketbeat.comREGENXBIO Inc.: REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 MillionMay 20, 2025 | finanznachrichten.deREGENXBIO announces royalty monetization agreement for up to $250MMay 20, 2025 | msn.comREGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 MillionMay 19, 2025 | prnewswire.comPoint72 Asia Singapore Pte. Ltd. Makes New $447,000 Investment in REGENXBIO Inc. (NASDAQ:RGNX)May 18, 2025 | marketbeat.comHudson Bay Capital Management LP Has $2.38 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)May 16, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Director Sells $162,961.82 in StockMay 15, 2025 | insidertrades.comEarnings Miss: REGENXBIO Inc. Missed EPS By 64% And Analysts Are Revising Their ForecastsMay 15, 2025 | finance.yahoo.comFDA Accepts Biologics License Application for Mucopolysaccharidosis II TreatmentMay 14, 2025 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Integral Health Asset Management LLCMay 14, 2025 | marketbeat.comRegenxbio stock rises on FDA’s priority review for MPS II therapyMay 13, 2025 | investing.comREGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS IIMay 13, 2025 | prnewswire.comCubist Systematic Strategies LLC Makes New $2.79 Million Investment in REGENXBIO Inc. (NASDAQ:RGNX)May 13, 2025 | marketbeat.comBrevan Howard Capital Management LP Buys Shares of 41,160 REGENXBIO Inc. (NASDAQ:RGNX)May 13, 2025 | marketbeat.comREGENXBIO Inc.: REGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational HighlightsMay 13, 2025 | finanznachrichten.deRegenxbio Inc (RGNX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and Financial ...May 13, 2025 | finance.yahoo.comREGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational HighlightsMay 12, 2025 | prnewswire.comBalyasny Asset Management L.P. Has $9.18 Million Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)May 12, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by BrokeragesMay 12, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in REGENXBIO Inc. (NASDAQ:RGNX)May 11, 2025 | marketbeat.comStifel Financial Corp Buys 39,564 Shares of REGENXBIO Inc. (NASDAQ:RGNX)May 10, 2025 | marketbeat.com5RGNX : What to Expect from Regenxbio's EarningsMay 9, 2025 | benzinga.comREGENXBIO (RGNX) Projected to Post Quarterly Earnings on WednesdayMay 9, 2025 | marketbeat.comREGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 28th Annual MeetingMay 8, 2025 | prnewswire.com Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address RGNX Media Mentions By Week RGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼0.891.00▲Average Medical News Sentiment RGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼45▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SPRY News TARS News IMCR News ARQT News OCUL News SDGR News ETNB News EVO News VERA News JANX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share REGENXBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
